Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS‐CoV‐2 in patients with pemphigus and bullous pemphigoid
Journal of the European Academy of Dermatology and Venereology · 2023
DOI: 10.1111/jdv.18967 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von F Solimani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Un…. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Immunization, Secondary, Pemphigoid, Bullous. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany.
ORCID-Profile: F Solimani, A Nast, K Meier, K Ghoreschi
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Solimani, F., Mesas-Fernández, A., Bodner, E., Carevic-Neri, M., Hasheminasab, M., Jakovljevicova, T., Philipp, A., Nast, A., Worm, M., Hilke, F. J., Meier, K., & Ghoreschi, K. (2023). Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS‐CoV‐2 in patients with pemphigus and bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.18967
Vancouver
Solimani F, Mesas-Fernández A, Bodner E, Carevic-Neri M, Hasheminasab M, Jakovljevicova T, et al. Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS‐CoV‐2 in patients with pemphigus and bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.18967
BibTeX
@article{Solimani2023,
author = {Solimani, F and Mesas-Fernández, A and Bodner, E and Carevic-Neri, M and Hasheminasab, M and Jakovljevicova, T and Philipp, A and Nast, A and Worm, M and Hilke, F J and Meier, K and Ghoreschi, K},
title = {Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS‐CoV‐2 in patients with pemphigus and bullous pemphigoid},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
doi = {10.1111/jdv.18967}
}
EUVIMED